Goldman Sachs’s Qiagen QGEN Stock Holding History

Goldman Sachs’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.2M	Sell	304,600 -68,600	-18%	-$3.25M	﹤0.01%	2885
2025 Q4	$16.8M	Buy	+373,200	New	+$17.3M	﹤0.01%	2556
2023 Q3	–	Sell	-289,141	Closed	-$13.8M	–	5800
2023 Q2	$13.8M	Buy	289,141 +79,405	+38%	+$3.83M	﹤0.01%	2159
2023 Q1	$10.2M	Buy	+209,736	New	+$10.7M	﹤0.01%	2403
2022 Q3	–	Sell	-47,153	Closed	-$2.36M	–	6485
2022 Q2	$2.36M	Hold	47,153	–	–	﹤0.01%	3907
2022 Q1	$2.45M	Hold	47,153	–	–	﹤0.01%	4065
2021 Q4	$2.78M	Buy	+47,153	New	+$2.7M	﹤0.01%	3962
2020 Q2	–	Sell	-141,458	Closed	-$6.24M	–	5430
2020 Q1	$6.24M	Buy	141,458 +127,312	+900%	+$4.97M	﹤0.01%	2470
2019 Q4	$507K	Buy	+14,146	New	+$526K	﹤0.01%	4501
2019 Q2	–	Sell	-188,611	Closed	-$8.14M	–	5310
2019 Q1	$8.14M	Buy	+188,611	New	+$7.59M	﹤0.01%	2586
2018 Q3	–	Sell	-94,306	Closed	-$3.62M	–	5752
2018 Q2	$3.62M	Buy	+94,306	New	+$3.47M	﹤0.01%	3191
2017 Q4	–	Sell	-46,304	Closed	-$1.55M	–	6589
2017 Q3	$1.55M	Buy	+46,304	New	+$1.6M	﹤0.01%	4198

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs's QGEN Position: Q1 2026 in Review

Goldman Sachs reduced its Qiagen (QGEN) stake by 54% in Q1 2026, selling an estimated $78.4M and leaving 1,391,327 shares worth $55.7M. The position accounts for 0.01% of the portfolio, ranked #1492.

Goldman Sachs first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $181M in Q4 2022. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Goldman Sachs held 1,391,327 shares of Qiagen worth $55.7M as of Q1 2026.
Goldman Sachs sold 1,655,657 Qiagen shares in Q1 2026, an estimated $78.4M.
Qiagen made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1492 holding.
Goldman Sachs first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
Goldman Sachs's Qiagen position peaked at $181M in Q4 2022.
344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.